Clinical Trial Detail

NCT ID NCT03175224
Title APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Apollomics Inc.
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

Bozitinib

Age Groups: adult senior

Additional content available in CKB BOOST